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Abstract
Introduction: Maxillary sinus augmentation is a predictable implant site development technique
for posterior atrophic maxillary ridges. However, graft consolidation requires adequate
angiogenesis and migration of osteogenic cells from native bone. Therefore, the amount of
residual bone height (RBH) may play a role in the rate of graft maturation. The purpose of this
study was to analyze the influence of RBH in the histomorphometric outcomes of maxillary sinus
augmentation procedures.
Material and methods: Patients in need of sinus augmentation were recruited for the study.
Customized radiographic guides were fabricated and a cone-beam computerized tomography scan
was obtained at baseline. Two examiners measured RBH on the scans at the locations marked by
the radiographic guide. Sinus grafting was performed by a lateral window approach using a
particulated mineralized allograft. Patients were followed up for 6 months. At the time of implant
placement, bone core biopsies were harvested using the radiographic guide, which was converted
into a surgical guide. Samples were histomorphometrically analyzed. Proportion of vital bone (%
VB), remaining allograft particles (%RA), and non-mineralized tissue (%NMT) were quantified.
Categorical analysis of correlation of RBH (<4 or  4 mm) with%VB and%RA was performed using
a statistical model.
Results: Twenty-one patients underwent sinus augmentation for a total of 21 sinuses. One patient
developed an infection after grafting and was excluded. Histomorphometric analysis revealed that
mean%VB was 20.47 ± 18.25, mean %RA was 29.04 ± 24.94, and average %NMT was
50.47 ± 12.76. No significant correlation between RBH and %VB (r = 0.016; P = 0.951), and RBH
and % (r = 0.009; P = 0.971) was found. Similarly, categorical analysis of correlation showed no
statistical significance.
Conclusion: These findings suggest that the remaining alveolar bone height does not appear to
influence the maturation and consolidation of an allograft in the maxillary sinus.
Residual alveolar bone height (RBH) is a crit-
ical anatomic factor that is carefully consid-
ered when planning a maxillary sinus
augmentation procedure. Given its direct
influence on implant primary stability, RBH
is commonly used to determine the implant
placement protocol of choice, either simulta-
neous or delayed. Abundant and compact
residual alveolar bone favors implant primary
stability. Conversely, achieving primary sta-
bility is often challenging in sites exhibiting
limited and coarse alveolar bone. In the vast
majority of maxillary sinus augmentation
protocols, the cut-off value to discern
whether to perform simultaneous or delayed
implant placement is in the range of 4 to 6
mm of RBH (Wang & Katranji 2008; Misch
et al. 2009; Nkenke & Stelzle 2009). Interest-
ingly, high implant survival rates have been
extensively reported in challenging clinical
scenarios, where implants were simulta-
neously placed with <5 mm of RBH (Peleg
et al. 1998, 1999, 2006; Rodriguez et al. 2003;
Mardinger et al. 2007). Therefore, the impact
of RBH on implant stability and survival has
been the subject of investigation (Fenner
et al. 2009a,b; Rios et al. 2009; Urban & Loz-
ada 2010). However, the importance of RBH
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is not exclusively related to implant stability
and implant success/survival rates. The
success of any bone grafting procedure,
including maxillary sinus augmentation,
relies on the provision of adequate angiogene-
sis and migration of osteogenic cells from
native bone (Busenlechner et al. 2009).
Therefore, it has been suggested and it can be
hypothesized that residual alveolar bone, as a
foundational source of cells and blood supply,
may play an important role in the consolida-
tion and maturation of a maxillary sinus
graft.
This case series study was aimed at evalu-
ating the influence of RBH on histomorpho-
metric outcomes, such as proportion of vital
bone (%VB) and remaining allograft particles
(%RA), following sinus augmentation using
an allogenic grafting material.
Material and methods
Patients
All participants in the study were recruited
and treated in the Graduate Periodontics
Clinic at the University of Michigan School
of Dentistry. The University of Michigan
Institutional Review Board approved the
experimental protocol (HUM00017520). The
study was also registered in the database of
the National Institutes of Health (NIH)
(http://www.clinicaltrials.gov) under the
identification number ‘NCT00868777’. Adult
patients between 18 and 85 years of age, in
need of unilateral or bilateral sinus augmen-
tation with delayed implant placement,
presenting physical status according to the
American Society of Anesthesiologists (ASA)
of I or II (http://www.asahq.org/clinical/phys-
icalstatus.htm), exhibiting RBH 6 mm
(assessed in periapical radiographs taken with
the paralleling technique), and O’Leary
plaque score  20% (O’Leary et al. 1972)
were included in the study. Patients were
excluded from the study if reported long-term
(>2 weeks) use of antibiotics within the
previous 3 months, use of medications
known to affect bone metabolism, uncon-
trolled conditions known to alter bone
metabolism, smoking more than 10 ciga-
rettes per day (Levin et al. 2004), history of
alcoholism or recreational drug abuse, muco-
cutaneous diseases, severe acute or chronic
sinus pathology (i.e. sarcoidosis, osteomas,
carcinomas), history of cancer, radiation to
the head and neck in the last 18 months, and
chemotherapy in the last 12 months or post-
operative complications related to these ther-
apies. Female patients who were pregnant or
attempting to get pregnant at the time of
screening were also excluded. Prior to inclu-
sion in the study, patients were required to
read, understand, and sign an informed con-
sent form.
Surgical planning
Stone models of all patients were obtained
from upper and lower alginate impressions.
Customized radiographic guides were fabri-
cated, as described elsewhere (Avila et al.
2010b). Cone-beam computed tomography
(CBCT) scans were obtained from each patient
using an i-CAT cone-beam machine (Imaging
Sciences International, Inc, Hatfield, PA,
USA). Only the maxilla and maxillary sinuses
were scanned in these patients to minimize
the radiation exposure unless a request to
include the mandible or other areas of the
skull in the same scan was made for other
purposes not related to this research study.
The Field of View (FOV) used was 6 cm for
the maxilla and maxillary sinuses only, 8 cm
when both jaws were included in the scan,
and 13 cm for the entire head. The machine
settings are fixed at 120 kVp and 18.66 mAs
for all scans regardless of the FOV used. Lin-
ear measurements to determine the RBH were
made using a radiopaque cylindrical marker
embedded in the guide as reference (Fig. 1).
Proprietary software provided by the manufac-
turer of the scanner was used for these mea-
surements (iCAT; Xoran Technologies Inc.,
Ann Arbor, MI, USA). Two calibrated, blinded
examiners specifically trained for this project
performed the measurements twice. Measure-
ments were averaged and expressed as the
mean value between the average of the two
sets of measurements that were indepen-
dently obtained by each examiner.
All participants were asked to follow a
pharmacologic protocol consisting of antibi-
otics (Amoxicillin 500 mg TID for 10 days,
starting 2 days before the surgery; or clinda-
mycin 300 mg TID for 10 days, starting
2 days before the surgery, for patients allergic
to penicillins) and oral corticosteroids (Dexa-
methasone 8 mg QD, 24 h before the surgery)
to control postoperative swelling and discom-
fort.
Maxillary sinus augmentation
Surgeries were performed under intravenous
sedation and local anesthesia (xylocaine 2%
1:100,000 or 1:50,000; Astra Zeneca USA,
Inc., Pharmaceuticals, Westborough, MA,
USA). In all cases, sinus augmentation was
performed following a lateral approach.
Fig. 1. Linear measurements using the radiopaque marker of the guide as a reference were performed to assess the
residual bone height (RBH).
© 2011 John Wiley & Sons A/S 1083 | Clin. Oral Impl. Res. 23, 2012 / 1082–1088
Avila-Ortiz et al Residual bone height and sinus augmentation
Briefly, a supracrestal incision was made
on the edentulous segment, with vertical
releases if needed to facilitate surgical access.
Following full-thickness flap elevation, a
lateral window was prepared with a round
diamond bur. After exposure of the Schneide-
rian membrane, specifically designed hand
instruments were used for its elevation
(Salvin Dental Specialties, Inc., Charlotte,
NC, USA). A mineralized bone allograft with
particle size ranging from 600 to 1250 lm
(MinerOss®; BioHorizons Inc., Birmingham,
AL, USA) was used as the sole grafting mate-
rial. Liquid antibiotic (clindamycin 150 mg/
ml) was added to the bone graft to minimize
the incidence of postoperative infection,
using a 1 ml of antibiotic to 2 ml of grafting
material ratio. An absorbable collagen mate-
rial (Collatape®; Zimmer Dental, Carlsbad,
CA, USA) was placed over the window for
hemostatic purposes. Soft tissues were
sutured attempting primary closure.
Postoperative instructions were provided
after completion of the surgical procedure.
Subjects were instructed to take the cortico-
steroid in decreasing daily doses of 6, 4, and
2 mg starting the day of the surgery. Patients
returned for a postoperative follow-up and
suture removal at 2 weeks. Thereafter, they
were evaluated at 1, 2, 3, 4, and 5 months
after maxillary sinus augmentation. Oral
hygiene instructions and supragingival deplaqu-
ing, if needed, were provided at these visits.
Bone core biopsy harvesting
At the 5-month follow-up visit, a second
CBCT scan utilizing the radiographic guide
was obtained. All of the follow-up CBCT
scans included the maxilla and maxillary
sinuses only. The FOV used was 6 cm and
the machine settings were fixed at 120 kVp
and 18.66 mAs. An analysis of the grafted
area was conducted to assess total bone
height achieved and to plan the implant
placement surgery, which was performed in
all cases between 6 and 7 months after
sinus augmentation. Implant placement was
performed under local infiltrative anesthesia.
The customized radiographic guide was
transformed into a surgical guide designed
to allow the use of a 3.75 mm diameter
trephine (Salvin Dental Specialties, Inc.), to
obtain samples from the exact locations
where the radiographic measurements were
made. Implant diameter was 4 mm in all
cases; therefore, in some cases, no drill was
utilized after the trephine. Implants were
placed in a submerged approach with a mini-
mum insertion torque of 30 N/cm2 to ensure
primary stability, following the manufac-
turer’s instructions (BioHorizons Internal
Implants; BioHorizons Inc., Birmingham, AL,
USA).
Histologic preparation
Immediately after harvesting, biopsies were
submerged in a 10% neutral buffered forma-
lin solution for fixation. Following deminer-
alization in EDTA, cores were dehydrated
and embedded in paraffin. Specimens were
sectioned following a protocol to accurately
obtain circular analyzable samples (Fig. 2).
Samples were stained with a conventional
hematoxylin–eosin technique and covers-
lipped for histologic and histomorphometric
analysis.
Histomorphometric analysis
Eight randomized images per sample were
captured using a bright field optical micro-
scope with a digital camera (Nikon E800
Light microscope with Diagnostics Spot-RT
cooled CCD digital camera, Tokyo, Japan)
connected to a computer containing special-
ized software (Image-Pro Plus 5.0; Media
Cybernetics, Bethesda, MD, USA). Vital bone
(VB), remaining allograft particle (RA), and
non-mineralized tissue (NMT) proportions
were measured separately by an experienced
examiner (Fig. 3).
Statistical analyses
All recorded variables (RBH, %VB, %RA, and
%NMT) were expressed as mean values. The
association of RBH with %VB and %RA was
quantified as a Pearson’s correlation coeffi-
cient. RBH was further divided into two cate-
gories: <4 and  4 mm. Subsequently, a
categorical analysis of correlation was
performed for the parameters %VB and %RA.
The statistical significance of each correla-
tion coefficient estimate was expressed as a
P-value, where P < 0.05 was considered
statistically significant. The correlation coef-
ficients obtained were adjusted for age and
Fig. 2. Histologic section of a representative histologic
sample (H&E 29).
Fig. 3. Computer software was used to perform the histomorphometric analysis. Histologic samples were analyzed
in full, comprising the total area.
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gender by calculating partial correlation coef-
ficients.
Results
Subjects and radiographic findings
Nine male patients and twelve female patients
with a mean age of 57.6 years (ranging from 23
to 69 years) participated in the study. After
initial CBCT analysis, four patients were
referred for otorhinolaryngological consulta-
tion, and all of them were cleared for the pro-
cedure. Mean baseline radiographic RBH was
4.25 ± 1.56 mm, ranging from 1.4 to 6.6 mm.
Inter-rater agreement coefficient for RBH was
0.988, which illustrates a robust positive cor-
relation between measurements made by the
two examiners. A total of 21 sinus augmenta-
tion procedures were performed. One patient
developed a sinusal infection during the initial
2 weeks following bone augmentation. This
patient was treated accordingly and the infec-
tion was controlled, but was still excluded
from the study. All remaining twenty patients
were regularly followed-up for the 6-month
healing period. In all these cases, augmenta-
tion achieved 6 months after sinus augmenta-
tion allowed proper implant placement. Mean
ridge height achieved after sinus augmenta-
tion was 15.9 ± 2.9 mm, ranging from 12 to
21.6 mm.
Histomorphometric analysis
Twenty bone biopsies were obtained and
sections at a distance of 10 mm from the
alveolar crest were prepared for histomorpho-
metric evaluation. Analysis of hematoxylin–
eosin sections revealed the presence of three
tissue components: VB, RA, and NMT. The
NMT was compatible with connective tissue
presenting two different, coexisting patterns:
fibrous and adipose, both in the presence of
randomly distributed blood vessels. Newly
formed vital bone and remaining allograft par-
ticles were basically distinguishable by the
presence of osteocytes in the lacunae. Bone-
lining cells (osteoblasts) were observed over
well-organized lamellar bone. Most remaining
allograft particles were in intimal contact
with newly formed bone, which supports the
osteoconductive properties of the material
used (Fig. 4). Mean %VB was 20.47 ± 18.25,
mean %RA was 29.04 ± 24.94, and a total of
50.47 ± 12.76 was found for mean percentage
of NMT. Histomorphometric data are
expressed in the form of a graphic bar diagram
in Fig. 5. In addition, histomorphometric
analysis results in relation to RBH for each
sinus are reported in Table 1.
Analysis of correlation
The correlation between radiographic RBH,
RBH <4 mm, and RBH  4 mm, and both %
VB and %RA was analyzed using linear
regression analysis (Scatter plot displayed in
Fig. 6). No significant correlation between
RBH and %VB (r = 0.016; P = 0.951), and
RBH and %RA (r = 0.009; P = 0.971) was
found when all data were pooled. Categorical
analysis of correlation after stratification of
RBH revealed no statistically significant cor-
relation for any of the associations considered
(Table 2). In light of these results, remaining
alveolar bone height does not appear to influ-
ence the maturation and consolidation of an
allograft in the maxillary sinus.
Discussion
RBH is a key factor to consider prior to
sinus augmentation. For most clinicians,
RBH determines if implant can be simulta-
neously placed or not, as RBH may influence
the possibility of achieving implant primary
stability. The higher the RBH, the better is
Fig. 4. Detail of a histologic sample showing vital bone
(red stars) in intimate contact with remaining allograft
particles (yellow circles), embedded in a non-mineral-
ized tissue matrix (blue squares). Black arrows indicate
the presence of blood vessels (H&E 209).
Fig. 5. Diagram showing the total mean values of each element analyzed in the histologic samples, including vital
bone (red bars), remaining allograft particle (yellow bars) and non-mineralized connective tissue (blue bars).
Table 1. Residual bone height(RBH) and histomorphometric data values per patient. Correspond-
ing average values of each parameter are shown at the bottom of the table
Patient RBH (mm) %VB %RA %NMT
01 3.1 4.3 70.18 25.52
02 6.0 63.17 7.85 28.98
03 1.4 0 51.56 48.44
04 3.8 29.21 7.83 62.96
05 1.4 37.16 5.55 57.29
06 6.1 13.85 44.97 41.18
07 3.7 2.21 55.67 42.12
08 4.8 7.2 56.55 36.25
09 4.7 29.74 1.76 68.5
10 5.7 13.33 25.82 60.85
11 3.1 22.23 13.99 63.78
12 3.2 0.77 63.34 35.89
13 4.9 36.89 0 63.11
14 4.9 28.16 7.36 64.48
15 3.3 1.52 45.84 52.64
16 3.9 41.71 0.86 57.43
17 2.4 47.58 2.86 49.56
18 6.0 5.17 60.41 34.42
19 6.0 3.62 40 56.38
20 6.6 21.72 18.49 59.79
Mean ± SD 4.25 ± 1.56 20.47 ± 18.25 29.04 ± 24.94 50.47 ± 12.76
%VB, proportion of vital bone; %RA, remaining allograft particles; %NMT, non-mineralized tissue.
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the chance of achieving primary implant
stability. Remaining bone heights of 4 and
6 mm have been proposed as the minimum
height that can assure a reliable, simulta-
neous implant placement. Fenner and
coworkers tested the hypothesis that a mini-
mum RBH is required to obtain better out-
comes using an animal model (i.e. minipigs).
In their study, the alveolar ridge was surgi-
cally remodeled, leaving the crestal aspect
intact, to create four different groups (two
specimens per group) based on the RBH: 2,
4, 6, and 8 mm. Then, the sinus was grafted
and implants were simultaneously placed
(six per specimen). Implant stability was
assessed using resonance frequency analysis
(RFA) at the time of implant placement,
6 months after placement, and 6 months
after functional loading. At that time, ani-
mals were sacrificed and samples including
the implants were retrieved to histologically
analyze bone-to-implant contact (BIC) ratio,
interthread bone area, peri-implant bone
area, and crestal bone resorption. It was
concluded that although implant stability
and BIC values were worse in the groups
with less RBH, the threshold of 5 mm is not
scientifically supported, as osseointegration
and implant survival were not significantly
affected (Fenner et al. 2009a,b). In a prospec-
tive clinical series study using private prac-
tice patients, Urban and Lozada compared
the success and survival rate of implants
placed following a two-stage approach in
clinical scenarios with minimal RBH
(3.5 mm) and patients with moderate
residual crestal bone (3.5–7 mm). One
hundred and fifty-six of 245 implants were
placed in the minimal RBH group. Only one
implant failed, at the time of abutment
placement, and three more failed to meet
the success criteria, after 5 years from abut-
ment connection. Overall, implant success
and survival rate in this group were 94.1%
and 99.4%, respectively. On the other hand,
implant success and survival rate were both
100% in the moderate RBH group. Interest-
ingly, these differences were not statistically
significant (Urban & Lozada 2010). These
results are in agreement with the observa-
tions reported in a systematic review aimed
at assessing the influence of RBH on the sur-
vival of implants placed simultaneously or
delayed after sinus augmentation. Data
reviewed from available literature suggest
that higher implant survival rate can be
expected with higher RBH. Nonetheless, the
implant survival rate associated with simul-
taneous implant placement in the presence
of less than 5 mm of RBH was found to be
very similar to that in cases of RBH higher
than or equal to 5 mm, being 96% and 99%,
respectively (Rios et al. 2009).
Nevertheless, besides implant stability and
survival rate, RBH may also play an impor-
tant role in the osteogenic potential of the
grafted area following maxillary sinus aug-
mentation. New vital bone formation rate, as
part of the process of graft consolidation, has
been proposed as primarily dependent on the
native maxillary bone (Zijderveld et al.
2005). It is important to highlight that bone
formation is not exclusively related to the
migration and activity of osteogenic cells
derived from native bone. The importance of
angiogenesis in human bone healing has
been greatly emphasized (Carano & Filvaroff
2003). Microvascular density is essential in
graft consolidation, although each biomate-
rial allows different microvascular coloniza-
tion (Boeck-Neto et al. 2009; Galindo-
Moreno et al. 2010). Zerbo et al. (2004)
showed, using the sinus augmentation
model, that b-TCP particles lying directly
over residual bone of the maxilla were
partially or completely replaced by vital bone
after 6 months, whereas particles located
more apical were still present, suggesting a
coronal to apical graft consolidation. Tadjo-
edin et al. (2003), showed that the front of
bone growth primarily originates from the
pre-existing native bone surfaces of the max-
illary sinus, particularly from the residual
alveolar bone. This concept has been
recently confirmed by Busenlechner and
collaborators, who demonstrated that bone
formation is significantly higher in the inter-
face of native bone with different grafting
materials, than in deeper areas. However, the
gradient of graft consolidation is characteris-
tic of each biomaterial, as reflected by the
osteogenic response of the host bone and the
degradation profile of the applied bone sub-
stitutes (Busenlechner et al. 2009). Our group
has previously reported maxillary sinus
dimensions influence vital bone formation
(Avila et al. 2010a). Similar findings were
reported by Artzi et al. (2005), who described
that bone area fraction, comparing b-TCP
and anorganic bovine bone, increased from
peripheral to deeper zones. In the present
study, we aimed at evaluating the influence
of RBH upon the formation of vital bone and
the presence of remaining particles using an
allograft as a sole grafting material for maxil-
lary sinus augmentation. No significant,
either positive or negative, correlation was
observed between radiographic RBH and both
%VB (R2 = 0.248; P = 0.126) and %RA
(R2 = 0.065; P = 0.384), even when RBH
was stratified into two groups using 4 mm
as the cut-off value. There was a non-linear
relationship for both parameters, as it can be
observed in the scatter plots included in
Fig. 6. Our findings are in agreement with
previously discussed available studies indi-
Fig. 6. Scatter plot diagrams illustrating the distribution of %VB and %RA relative to RBH with the corresponding
correlation coefficient values for pooled RBH and each RBH category (<4 and  4 mm), separated by a dotted line.
Table 2. Analysis of correlation values
Correlation analysis %VB %RA
RBH (n = 20) r 0.016 0.009
P-value 0.951 0.971
RBH <4 mm (n = 10) r 0.211 0.207
P-value 0.617 0.622
RBH 4 mm (n = 10) r 0.091 0.179
P-value 0.830 0.672
RBH, residual bone height; %VB, proportion of vital bone; %RA, remaining allograft particles.
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cating that RBH may not be such a critical
factor to achieve successful outcomes follow-
ing maxillary sinus augmentation. However,
our aim was to evaluate initial maxillary
sinus outcomes, instead of long-term implant
or implant-supported prostheses success/sur-
vival rate. It is possible that implant and
implant-supported restorations survival is
influenced by the amount of remaining
alveolar bone after functional loading. A post-
hoc power analysis calculation, performed
using a specialized software (Faul et al. 2007),
revealed that the study has a power of 68%. It
is generally acknowledged that 85% is the
standard power required to reject the null
hypothesis when it is truly false. This
suggests that further studies based on an a pri-
ori power analysis with RBH as the primary
outcome, using the information presented in
this pilot study, should be conducted to shed
more light on this interesting topic. Further-
more, another limitation of this study stems
from the interindividual variability in histo-
morphometric outcomes, particularly in terms
of vital bone and remaining allograft particle,
as reflected in Table 1 and Fig. 5. Despite our
efforts to enroll a homogeneous patient popu-
lation, based on the inclusion and exclusion
criteria, this marked variability could be
explained by individual healing potential, and
other confounders such as the occurrence of
concomitant respiratory tract pathology (e.g.
common viral cold) during the healing period.
The use of prophylactic antibiotics prior to
sinus augmentation procedures is a contro-
versial topic. In general, the use of antibiotic
prophylaxis is generally limited to those
cases in which there is a concomitant local
infection and when patients with comorbid
conditions or immunodepression are treated.
The rationale is to avoid pharmacologic aller-
gic reactions and antibiotic resistances. Inter-
estingly, Powell et al. (2005), showed that
patients who received antibiotics exhibited a
higher rate of infection than patients who
had no antibiotic coverage, although the
difference was not statistically significant. In
the population they studied, no patient who
underwent maxillary sinus augmentation
(n = 15) developed an infection. However,
‘the prophylactic use of systemic and local
antibiotics and glucocorticosteroids can
reduce the risk of infection’ (Misch 1992).
This recommendation finds a clear indication
in the event of Schneiderian membrane perfo-
ration, since a retrograde bacterial coloniza-
tion from the respiratory tract may lead to an
infection of the grafted area. Given the
impossibility of predicting in which cases
that complication is going to occur, to
provide a standardized treatment to all
patients participating in this controlled
study, we followed the pharmacologic proto-
col proposed by Resnik & Misch (2008).
Finally, to our knowledge, there is limited
information available with regard to impact
of local antibiotic application in the healing
following oral bone grafting and conflicting
results have been reported (Kim et al. 2004;
Oghli & Steveling 2010). We consider that,
although possible, it is unlikely that the use
of liquid clindamycin in conjunction with
the bone grafting material has a determining
influence in bone healing and histomorpho-
metric values of samples harvested after a
6-month healing period.
Conclusions
Our findings suggest that remaining alveolar
bone height does not influence the matura-
tion and consolidation of an allograft 6
months after maxillary sinus augmentation.
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